Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Drug Importation Would Undermine Waxman/Hatch, Generic Industry Says

Executive Summary

A legalized system of drug importation would undermine Waxman/Hatch incentives for generic drug development, the Generic Pharmaceutical Association told the HHS importation task force April 5

You may also be interested in...



Rx Import Bills Could Violate Takings Clause Of Constitution – Sen. Hatch

A prescription drug importation law could violate the Takings Clause of the U.S. Constitution if it requires manufacturers to sell products to exporters in other countries at below-market prices, Senate Judiciary Committee Chairman Orrin Hatch (R-Utah) said at a July 14 hearing

Rx Import Bills Could Violate Takings Clause Of Constitution – Sen. Hatch

A prescription drug importation law could violate the Takings Clause of the U.S. Constitution if it requires manufacturers to sell products to exporters in other countries at below-market prices, Senate Judiciary Committee Chairman Orrin Hatch (R-Utah) said at a July 14 hearing

Rx Importation Unsustainable Because Of Supply/Demand Imbalance – HDMA

Increased demand for a small amount of Canadian pharmaceuticals would make a legalized importation system unsustainable, drug distributors told the HHS importation task force

Latest Headlines
See All
UsernamePublicRestriction

Register

PS043706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel